Interventional Cardiology Review

1 week ago | radcliffecardiology.com | Kieran F. Docherty |Clara Saldarriaga |Gianluigi Savarese

Learning Objectives Discuss why getting cardiorenal patients onto GDMT is challenging Recall the residual risk posed by the co-existence of heart failure and chronic kidney disease Adopt practical approaches to managing cardiorenal patients based on examples explored during this activity Detail gaps in current standards of care for cardiorenal patients Discuss ongoing efforts aimed at addressing residual risk, hyperkalaemia and clinical inertia in cardiorenal disease Target Audience...

2 weeks ago | radcliffecardiology.com | Jonathan Byrne |Jonathan Curio |Michael G. Mullen |Patrick W. Serruys

EuroPCR 25 - Real-world findings from the REVEAL-AFMR registry show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR). We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from the REVEAL-AFMR registry to investigate the impact of TEER on prognosis in patients with AFMR.

Feb 28, 2025 | radcliffecardiology.com | Gurleen Kaur |Saman Nematollahi |Thomas Das

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.

Feb 20, 2025 | radcliffecardiology.com | Weijian Huang |Pablo Vazquez

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.

Feb 20, 2025 | radcliffecardiology.com | Pablo Vazquez |Marat Fudim |Barry A. Borlaug |Alexander Sullivan

THT Conference 2025 - Findings show catheter ablation of the right greater splanchnic nerve (GSN) in patients with heart failure with preserved ejection fraction (HFpEF) reduced estimated stressed blood volume in patients whether the ablation caused clinical benefits or not. This outcome indicates a confirmation of technical success that correlates with prior single-arm study findings.